UNSPSC 85815304: Introduction of analgesics, hypnotics, sedatives into respiratory tract, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of analgesics, hypnotics, sedatives into respiratory tract, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0F3NZ

UNSPSC 85815304 Introduction of analgesics, hypnotics, sedatives into respiratory tract, percutaneous approach is a Commodity code that shows minimal alignment between the abstract code name and recent state and local procurement activity. The code nominally describes a medical procedure—pharmaceutical administration via inhalation or skin contact—yet the recent opportunities posted under this taxonomy code do not reflect that narrow clinical scope. Instead, the opportunities span virtual telehealth urgent care, occupational health services, medical director roles, nursing home operations, behavioral health programs, wellness platforms, and opioid treatment initiatives. This mismatch signals that state and local procurement offices are either misclassifying health-related opportunities under this code or the code's technical definition does not map cleanly to how jurisdictions actually categorize their health service buys.

The issuing bodies in the recent-opportunities block include state health authorities (Nevada), county health systems and departments (Santa Clara, San Mateo, DeKalb, Forsyth, Brevard, Seminole, Boulder), city governments (Phoenix, Ocala, Atlanta), school districts (Parkway), and specialized public entities (Inland Empire Health Plan in California, Ventura County Behavioral Health). The geographic spread reflects activity across California, Georgia, Nevada, Florida, Colorado, Kansas, and other states with no clear concentration. Because the code shows fundamental scope misalignment—the recent solicitations (virtual urgent care, EMT staffing, occupational health exams, cancer registry services, medical director services, and opioid treatment programs) bear no substantive relationship to the code's nominal focus on respiratory or percutaneous pharmaceutical introduction—the code does not warrant pursuit as a market signal. The activity is real and the issuing bodies are material, but they are not buying the service this code nominally describes.